Using microdosing to induct patients into a long-acting injectable buprenorphine depot medication in low threshold community settings : a case study
MetadataShow full item record
Altmetrics Handle Statistics
Altmetrics DOI Statistics
Healthcare innovation has never been more important as it is now when the world is facing up to the unprecedented challenges brought by the COVID-19 pandemic. Within addictions services in Scotland, the priority has been to tackle our rising drug related death rate by maintaining and improving access to treatment while protecting frontline workers and managing operational challenges as a result of the pandemic. We present here a case study of five patients with opioid use disorder whose treatment represents a confluence of three important Medication Assisted Treatment (MAT) service innovations. The first was a low threshold drop in and outreach MAT service to rapidly and safely initiate opiate replacement therapy (ORT). The second was the provision of a microdosing regimen to enable same day induction to oral buprenorphine while minimizing the risk of precipitated opioid withdrawals and/or treatment disengagement. The third was rapid transitioning to an injectable long-acting buprenorphine depot which reduced unnecessary face to face patient contact and treatment non-adherence. This case study of five patients highlights the valuable role that buprenorphine microdosing can play in making induction to long-acting buprenorphine depot feasible to a broader range of patients, including those on a high dose methadone treatment regime.
Tay Wee Teck , J B , Baldacchino , A M , Gibson , L & Lafferty , C 2021 , ' Using microdosing to induct patients into a long-acting injectable buprenorphine depot medication in low threshold community settings : a case study ' , Frontiers in Pharmacology , vol. 12 , 631784 . https://doi.org/10.3389/fphar.2021.631784
Frontiers in Pharmacology
Copyright © 2021 Tay Wee Teck, Baldacchino, Gibson and Lafferty. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.